Characterization of the minimal residual disease state reveals distinct evolutionary trajectories of human glioblastoma.
Qazi MA, Salim SK, Brown KR, Mikolajewicz N, Savage N, Han H, Subapanditha MK, Bakhshinyan D, Nixon A, Vora P, Desmond K, Chokshi C, Singh M, Khoo A, Macklin A, Khan S, Tatari N, Winegarden N, Richards L, Pugh T, Bock N, Mansouri A, Venugopal C, Kislinger T, Goyal S, Moffat J, Singh SK.
Qazi MA, et al. Among authors: mansouri a.
Cell Rep. 2022 Sep 27;40(13):111420. doi: 10.1016/j.celrep.2022.111420.
Cell Rep. 2022.
PMID: 36170831
Free article.